Close

Articles Posted in Pradaxa

Updated:

Boston Product Liability Attorneys Talk Dangers of Taking Pradaxa

Patients with a serious medical condition known as atrial fibrillation, also known as “Afib,” a type of irregular heartbeat, are generally required to take a prescription blood thinner or oral anticoagulant medication.  Blood thinners have been on the market for decades, and the most popular one is Warfarin, invented in…

Updated:

Pradaxa Hopes to Grab Market Share as Xarelto Antidote Fails FDA Approval

Pharmaceutical industry experts have been buzzing recently about the U.S. Food & Drug Administration’s rejection of approval for Xarelto. Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. First, let’s look at what these two drugs do.  Xarelto and Pradaxa and…

Updated:

Possible New Way to Stop Bleeding Disorder Caused by Pradaxa

Patients who suffer from a serious medical condition must take a blood thinner or anticlotting agent to prevent the formation of blood clots that can be deadly.  Patients who suffer from deep vein thrombosis (DVT) and various other conditions need to take these medications to prevent potentially deadly medical conditions…

Updated:

A Look at Atrial Fibrillation Treatment Options, Including Pradaxa

Atrial Fibrillation (Afib) is a serious medical condition that affects about one in ten Americans over the age of 65.  If someone suffers from atrial fibrillation, which is defined as an irregular heartbeat not associated with a heart valve defect, they will experience what doctors call “bouts” of the condition.…

Updated:

FDA Approves Pradaxa for Hip Replacement Patients

Pradaxa is a medication used to reduce the risk of serious clotting disorder in patients who suffer from a potentially serious medical condition known as atrial fibrillation (Afib). Afib patients are at higher risk for forming large blood clots deep within the veins on their legs and other extremities.   These…

Updated:

Watchdog Claims FDA “lax” When Reviewing Blood Thinner Pradaxa

According to a recent news article from the Washington Post, a federal watch group reports the United States Food and Drug Administration (FDA) exercised “lax” judgment and made “questionable” decisions to be accommodating to the pharmaceutical maker Boehringer Ingelheim when reviewing its application for the anticlotting medication known as Pradaxa.…

Contact Us